A “live”/supervised online course consisting of four modules over 6 weeks and focusing on advanced methods of decision analytic modelling for economic evaluation. The course is aimed at health economists and those health professionals with experience of health economics who… Read More »Decision Modelling for Health Economic Evaluation
The in-person course, led by Professor Andrea Manca, will take place at the University of York from Tuesday 8th to Thursday 10th September 2026. This three-day in-person Advanced course focuses on the use of statistical methods for the analysis of… Read More »Statistical Methods in Economic Evaluation for HTA – Advanced
The UK government is reportedly preparing to raise NICE’s cost-effectiveness threshold by 25%, as a bargaining chip to avoid US pharmaceutical tariffs. It’s time for health economists to reclaim this space and defend evidence-based decision-making.
Chris Sampson challenges a recent article in The Lancet claiming that NICE recommendations reduce population health.
The Health Economics Policy Lab (HEPL) at University College London (UCL) is excited to announce our first ever conference. It will be a celebration of the exciting work and innovations in economic evaluations alongside trials and using real world evidence.… Read More »Economic evaluations alongside clinical trials and using real world evidence
Chris shares his review of the summer 2024 HESG meeting at the University of Warwick, which was brimming with discussion of economic evaluation, career pathways, and the general election.
Free registration for the MEED Research Forum 2024 is now open! This year marks the 5th edition of the MEED Research Forum. For this year’s edition, we’re expanding the scope to include digital, data-driven technologies, and devices (MedTech) alongside diagnostics as in previous years.… Read More »Methods of the Economic Evaluation of Diagnostics (MEED) 2024
Prof Philip Clarke considers the challenge of reproducibility in the discipline of health economics, discussing several initiatives that can support high quality research and better decision-making.
Chris summarises the latest issue of AHEHP, which is full of novel topics and methods. Highlights include a new resource use measure and several reviews on cost-effectiveness and HTA.
An introduction to the work of Edgar Sydenstricker, a forgotten health economist who researched the 1918-20 influenza pandemic, the Great Depression, and inequalities in the impact of diseases such as pellagra.